New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
17:30 EDTAEZSAeterna Zentaris files to sell $50M of common stock 'at-the-market'
Aeterna Zentaris announced that its shelf registration statement on Form F-3 previously filed with the SEC has been declared effective by the SEC. Under the shelf registration statement, the company may offer and sell from time to time, in one or more public offerings in the United States, up to $50M of common shares in one or more "at-the-market" distribution programs, during a 36-month period.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
07:31 EDTAEZSAeterna Zentaris recruited 500 patients for pivotal Phase 3 ZoptEC study
Subscribe for More Information
June 25, 2015
07:37 EDTAEZSAeterna Zentaris selects Ergomed to conduct Phase 3 clinical trial of Macrilen
Aeterna Zentaris announced that it has executed a definitive agreement with Ergomed, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen, a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use